VANCOUVER, March 14, 2013 /CNW Telbec/ - Akela Pharma, Inc. (the
"Corporation") has announced that the asset foreclosure on its wholly
owned subsidiary, Formulation Technologies, LLC d/b/a PharmaForm, was
completed on March 9, 2013. The Corporation and its subsidiaries have
ceased operations. All employees, officers and directors of the
Corporation have resigned or been terminated.
SOURCE: AKELA PHARMA INC.
For further information:
Akela Pharma, Inc.